Evaluation of a needle-free injection system for administration of cloprostenol for luteolysis in lactating dairy cows

Authors

  • A. Leslie Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506
  • M. Kleinhenz Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506
  • V. Gomez Leon Department of Animal Sciences and Industry, Kansas State University, Manhattan, KS 66506
  • S. Hurtado Department of Animal Sciences and Industry, Kansas State University, Manhattan, KS 66506
  • A. Machado Department of Animal Sciences and Industry, Kansas State University, Manhattan, KS 66506
  • M. Weeder Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506
  • A. Curtis Department of Anatomy and Physiology, Kansas State University, Manhattan, KS 66506
  • J. Coetzee Department of Anatomy and Physiology, Kansas State University, Manhattan, KS 66506

DOI:

https://doi.org/10.21423/aabppro20238934

Abstract

Luteolytic drugs are critical for managing reproductive success in dairy cows. Currently prostaglandin analogs are only ap­proved for intramuscular injection. The utilization of a needle and syringe for administration of any drug can result in needle-stick injuries to workers. Furthermore, needle-free injection systems have been shown to eliminate transmission of blood­borne pathogens, such as anaplasmosis, in cattle. Data on the efficacy of needle-free injection systems and their application in an estrous synchronization protocol has not been reported. The objective of the present study was to evaluate the effective­ness of utilizing a needle-free injection system (Pulse Needle­Free Systems, Lenexa, KS) for the intramuscular delivery of clo­prostenol (Estrumate®, Merck Animal Health, Madison, NJ) for the purpose of estrous synchronization in lactating dairy cows.

Downloads

Published

2024-05-10

Most read articles by the same author(s)